You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for New Drug Application (NDA): 021489


✉ Email this page to a colleague

« Back to Dashboard


NDA 021489 describes PROHANCE MULTIPACK, which is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. Additional details are available on the PROHANCE MULTIPACK profile page.

The generic ingredient in PROHANCE MULTIPACK is gadoteridol. One supplier is listed for this compound. Additional details are available on the gadoteridol profile page.
Summary for 021489
Tradename:PROHANCE MULTIPACK
Applicant:Bracco
Ingredient:gadoteridol
Patents:0
Pharmacology for NDA: 021489
Suppliers and Packaging for NDA: 021489
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489 NDA Bracco Diagnostics Inc 0270-1111 0270-1111-70 5 VIAL, PHARMACY BULK PACKAGE in 1 BOX (0270-1111-70) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE
PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489 NDA Bracco Diagnostics Inc 0270-1111 0270-1111-85 5 VIAL, PHARMACY BULK PACKAGE in 1 BOX (0270-1111-85) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength279.3MG/ML
Approval Date:Oct 9, 2003TE:RLD:Yes

Expired US Patents for NDA 021489

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 ⤷  Subscribe ⤷  Subscribe
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 ⤷  Subscribe ⤷  Subscribe
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 ⤷  Subscribe ⤷  Subscribe
Bracco PROHANCE MULTIPACK gadoteridol INJECTABLE;INJECTION 021489-001 Oct 9, 2003 ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.